Montpellier and Taiwan, March 20th 2025 – A specialist in the minimally invasive treatment of cancerous tumors, Quantum Surgical extends its presence in Taiwan in partnership with Unison Healthcare Group. Quantum Surgical’s robotic platform Epione is already used in fifteen cancer centers in Europe and in the USA.
Quantum Surgical develops the Epione® robotic platform. It assists physicians in performing percutaneous tumor ablations, where one or more needles are inserted through the skin to destroy the tumor. This minimally invasive treatment provides patients with a safe and effective alternative to surgery.
Epione can treat tumors located in the abdomen (liver, kidney, pancreas) in the lungs, and is currently used to treat tumors in the liver in about fifteen cancer centers worldwide. Over 800 patients have already been treated worldwide.
Quantum Surgical now partners with UHG to strategically expand activities in Taiwan, according to the latest statistics, the number of newly diagnosed cancer cases in Taiwan in 2022 is estimated to be 132,293, an increase of 8,531 cases compared to 2021.
Bertin Nahum, CEO and co-founder of Quantum Surgical explains “We are thrilled to expand our activities in Taiwan with Unison Healthcare Group, as our mission is to improve early-stage cancer treatment worldwide and ensure that as many cancer patients as possible can benefit from our minimally invasive technology”.
Daniel Shih, Chairman and President of Unison Healthcare Group (UHG) declares ”The partnership between UHG and Quantum Surgical’s founders began with their former venture Medtech and the ROSA surgical robot. The Group is honored to work with Quantum Surgical again to promote the minimally invasive surgical robotic system for cancer treatment. We hope that the new generation of minimally invasive cancer surgical robots will elevate the quality of Taiwan’s cancer treatment industry”.
About Quantum Surgical
Quantum Surgical is a French medical robotics company co-founded in 2017 by Bertin Nahum, CEO. With a dynamic team of over 10 employees, the company is headquartered in Montpellier, France, and has offices in Miami, Florida.
Its Epione® platform is dedicated to the curative and early treatment of cancers. Quantum Surgical thus offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better targeted and less invasive treatments. Hundreds of patients have already been treated worldwide.
Quantum Surgical was awarded the prestigious Prix Galien USA in 2022, the equivalent of the Nobel Prize for biopharmaceutical research, and joined in 2023 the governmental French Tech 2030 program that supports top emerging actors in disruptive innovation.
More information: www.quantumsurgical.com
Press contact Quantum Surgical
Stéphanie Moy
s.moy@quantumsurgical.com
Tel. : +33 (0)6 32 55 85 48
About Unison Healthcare Group
Founded in 1995, Unison Healthcare Group (UHG) has always been committed to providing the highest quality healthcare services in Taiwan by upholding the brand mission of “Inspiring Healthcare for Happiness”. Since the introduction of radiological equipment in the 1960s, the Group has continued to expand from “precision diagnosis” to “precision medicine”. In 2009, UHG embarked on the era of medical robots, and has been distributing a number of high-end surgical robots for neurosurgery, orthopedics, and other medical fields, which has revolutionized the delivery of healthcare and clinical services. Meanwhile, the Group has also developed a “one-stop comprehensive service” to provide medical institutions, private organizations and individuals with a genuine “Total/Integrated Solution” for medical and healthcare services. Moreover, UHG is fully committed to promoting ESG and obtained the B Corp Certification in 2022.
Press contact Unison Healthcare Group
Athena Liu
Tel: +886-939392092
